Effect of rs6923761 gene variant of glucagon-like peptide 1 receptor on metabolic response and weight loss after a 3-month intervention with a hypocaloric diet

Journal of Endocrinological Investigation

Volumn 37, Issue 10, 2014, Pages 935-939

  De Luis, Daniel Antonio ^a   Aller, Rocío ^a   Izaola, Olatz ^a   Lopez, J J ^a   Gomez, E ^a   Torres, B ^a   Soto, G Diaz ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Cardiovascular risk factors; Glucagon like peptide 1 receptor; Hypocaloric diet; rs6923761; Weight loss

Indexed keywords

CARBOHYDRATE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CALORIE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAT MASS; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLISM; OBESITY; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT CHANGE; WEIGHT REDUCTION; CALORIC RESTRICTION; FOLLOW UP; GENETICS; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME;

ADULT; CALORIC RESTRICTION; FEMALE; FOLLOW-UP STUDIES; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; HUMANS; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84919347056     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-014-0117-2     Document Type: Article

References (22)

1. Kieffer TJ, Habener JF (1999) The glucagon-like peptides. Endocr Rev 20:876-913
2. Holst JJ (2002) Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1. Diabetes/Metab Res Rev 18:430-441
3. Bullock BP, Heller RS, Habener JF (1996) Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137:2968-2978
4. Thorens B (1992) Expression cloning of the pancreatic β-cell receptor for the gluco-incretin hormone glucagon peptide-1. Proc Natl Acad Sci USA 89:8641-8645
5. Tokuyama Y, Matsui K, Egashira T, Nozaki O, Ishizuka T, Kanatsuka A (2004) Five missense mutations in glucagon-like peptide 1 receptor gene in Japanese population. Diabetes Res Clin Pract 66:63-69
6. Beinborn M, Worrall CI, McBride MW, Kopin AS (2005) A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness. Regul Pept 130:1-6
7. Sathananthan A, Dalla C, Micheletto F, ZInsmeister A, Camilleri M, Giesler P (2010) Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects. Diabetes Care 33:2074-2076
8. Kumada M, Kihara S, Sumitsuji S (2003) Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23:85-89
9. Shimomoura I, Hammer RE, Ikemoto S (1999) Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401:73-76
10. Steppan CM, Bailey ST, Bhat S (2001) The hormone resistin links obesity to diabetes. Nature 409:307-312
11. Matsuzawa Y (2005) Adipocytokines: emerging therapeutic targets. Curr Atheroscler Rep 7:58-62
12. Mataix J, Mañas M (2003) Tablas de composición de alimentos españoles. University of Granada, Granada
13. Duart MJ, Arroyo CO, Moreno JL (2002) Validation of a insulin model for the reactions in RIA. Clin Chem Lab Med 40:1161-1167
14. Mathews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-414
15. Pfutzner A, Langefeld M, Kunt T et al (2003) Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin lab 49:571-576
16. Meier U, Gressner M (2004) Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, Ghrelin, adiponectin, and resistin. Clin Chem 50:1511-1525
17. Suominen P (2004) Evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations. Clin Chem 50:219-221
18. Lubrano V, Cocci F, Battaglia D et al (2005) Usefulness of high-sensitivity IL6 measurement for clinical characterization of patients with coronary artery disease. J Clin Lab Anal 19:110-114
19. Fortin JP, Schroeder J, Zhu Y, Beinborn M, Kopin A (2010) Pharmacological characterization of human incretin receptor missense variants. J Pharmacol Exp Ther 332:274-280
20. Sheikh H, Dougherty L, Hayden E, Klein D (2010) GLP-1 R gene polymorphism Leu260Phe is associated with morning cortisol in preschoolers. Prog Neuro Biol Psyc 34:980-983
21. Scrocchi LA, Marshall BA, Cook SM, Brubaker DJ (1998) Identification of GLP-1 actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling. Diabetes 47:632-639
22. Barash A, de grado T, Cano O, Bordiu E. Effect of GLP-1 receptor variants on weight loss and comorbidities in obese patients under bariatric surgery. 54 Congress of Endocrinology Society Madrid 2012. Abstract